# A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control

> **NCT00830739** · — · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 61 (actual)

## Conditions studied

- Tobacco Use Disorder
- Nicotine Dependence

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00830739
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11-25
- **Primary completion:** —
- **Final completion:** 2013-02-26
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830739, "A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00830739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*